JOBY Q3 2026 10-Q: Joby Aviation Earnings Analysis
Aviation earnings brief on the Joby Aviation (JOBY) Q3 2026 10-Q filing — the numbers that matter, the fleet, capacity and cost themes behind them, and what they signal for the stock.
Listen to this episode
What the filing says
A summary of management's own discussion and analysis from the filing.
Joby Aviation MD&A Summary (Q3 2026)
Company Overview
Joby Aviation is a pre-revenue eVTOL air taxi developer that acquired Blade Urban Air Mobility in August 2025, providing its first source of passenger revenue. The company has an accumulated deficit of $3,353 million as of September 30, 2026, and has never generated positive operating cash flow since its 2009 founding.
---
1. Key Performance Drivers
- Blade acquisition (August 2025) is the primary driver of current revenue, providing immediate market access, customer base, and operational infrastructure in New York City and Southern Europe
- FAA certification progress is the central operational milestone; management reports completion of three of five certification stages, with the fourth stage more than 80% complete
- eIPP flight operations commenced in September 2026 in Dallas-Fort Worth, representing the first real-world operational activity
- U.S. Air Force contracts expanded from $20 million to nearly $37 million for autonomous flight technology
---
2. Capacity and Demand Trends
- No commercial eVTOL capacity exists yet; the UAM market remains undeveloped
- Management targets first passenger flights in 2026
- Aircraft is designed for routes up to 100 miles, with management stating that over 99% of urban routes in cities like New York and Los Angeles fall within this range
- Blade passenger revenue is seasonal, peaking in Q2 and Q3 due to summer travel demand
---
3. Revenue and Margin Commentary
- Q3 2026 revenue: $55.1 million, up $32.5 million (144%) from $22.6 million in Q3 2025
- Revenue growth was driven entirely by inclusion of a full quarter of Blade passenger revenue versus approximately one month post-acquisition in the prior year period
- Government flight services revenue declined year-over-year, partially offsetting Blade growth
- Cost of Revenue: $39.0 million in Q3 2026 versus $10.1 million in Q3 2025, rising proportionally with Blade's full-quarter inclusion
- Gross margin remains thin given the early-stage nature of Blade operations and ongoing service costs
---
4. Cost Factors
- R&D expenses increased 40% to $208.6 million in Q3 2026, driven by higher personnel costs supporting engineering, software development, prototype manufacturing, and certification activities; management expects R&D to continue increasing
- SG&A expenses increased 90% to $85.6 million in Q3 2026, driven by full-quarter Blade consolidation, increased legal and marketing spending, higher stock-based compensation, and Resonant Sciences acquisition-related costs
- Tariffs have not materially impacted operations to date but are identified as a future risk as manufacturing scales
- Traditional airline cost factors (fuel, labor for flight operations, maintenance) are reflected in Cost of Revenue but are not separately quantified in this filing
---
5. Forward-Looking Statements
- Management targets first passenger flights in 2026 under the eIPP program
- Plans to expand eIPP activities in high-density metropolitan markets pending regulatory approvals
- Acquisition of Resonant Sciences for approximately $500 million is pending, with the defense business to operate as a separate subsidiary
- R&D and SG&A expenses are both expected to increase as headcount grows and operations scale
- Management expects international expansion via FAA bilateral agreements, with active certification applications in the UK, Japan, and UAE
Full transcript
The complete episode in text. Prefer reading to listening — this is the same analysis, word for word.
Sarah: Joby Aviation just reported one hundred forty-four percent revenue growth year-over-year, and their operating loss widened by nearly a hundred million dollars in the same breath.
Mike: That's the core tension in this filing. The revenue number looks dramatic until you understand where it came from — and the loss number looks alarming until you understand what they're spending it on. Neither figure means what it appears to mean at first glance, and that's straight out of the ten-Q they filed this week.
Sarah: If you want same-week reads on filings like this one, follow the show so you never miss an episode.
Mike: If we reduce this filing to one sentence, it's this: Joby Aviation is burning capital at an accelerating rate to reach a certification finish line that is now measurably close, but the clock and the cash balance are in a race that has no margin for a slip. Based on this filing, Joby Aviation is operating in structural reset — a company that has not yet generated a dollar of eVTOL revenue, is absorbing a major acquisition, and is simultaneously pursuing a five-hundred-million-dollar defense deal, all while the FAA type certification process sits at more than eighty percent complete on stage four of five.
Sarah: That thesis is going to run through everything we look at today. Let's start with what actually changed between the third quarter of 2025 and the third quarter of 2026, because the numbers require some unpacking.
Mike: They do. Revenue came in at fifty-five point one million dollars for the quarter ending September 30, 2026, compared to twenty-two point six million for the same quarter one year earlier. That is a hundred and forty-four percent increase year-over-year. But here is the critical context: that entire revenue base comes from Blade Urban Air Mobility, which Joby acquired in August 2025. In the third quarter of 2025, Joby only had approximately one month of Blade revenue post-acquisition. In the third quarter of 2026, they had a full quarter. So the growth rate is almost entirely a calendar artifact of the acquisition timing, not an acceleration in underlying demand.
Sarah: And the cost side moved in the same direction.
Mike: Proportionally, yes. Cost of revenue rose from ten point one million in the third quarter of 2025 to thirty-nine million in the third quarter of 2026, again reflecting full-quarter Blade consolidation. The gross margin on Blade's charter brokerage operations remains thin, which is consistent with what you'd expect from an asset-light air charter intermediary. But the bigger cost story is in research and development. R&D expenses increased forty percent to two hundred eight point six million in the third quarter of 2026. Management was explicit in the MD&A that this was driven by higher personnel costs supporting engineering, software development, prototype manufacturing, and certification activities. And they stated directly that they expect R&D to continue increasing.
Sarah: So operating income — or operating loss, more precisely — widened significantly.
Mike: Operating loss came in at two hundred seventy-eight point one million for the quarter, compared to one hundred eighty-one point seven million in the same quarter of 2025. That is a deterioration of ninety-six point four million dollars year-over-year. For context, that widening is larger than the entire revenue base of the company. SG&A also expanded sharply, up ninety percent to eighty-five point six million, driven by full-quarter Blade consolidation, increased legal and marketing spending, higher stock-based compensation, and costs related to the pending Resonant Sciences acquisition. If the R&D and SG&A trajectory persists at this rate into 2027, the quarterly cash consumption will outpace the current balance within a defined number of quarters — and we will get precise about that when we hit the liquidity section.
Sarah: Let's talk about what management is actually saying in the MD&A, because the tone matters as much as the numbers in a pre-revenue filing like this.
Mike: Management's language in this filing is notably milestone-forward. They are not discussing revenue optimization or margin improvement — those concepts are essentially absent. Instead, the MD&A is structured around certification progress, operational firsts, and strategic positioning. The most significant statement on certification reads, and I'm paraphrasing closely from the filing: they have completed or substantially completed three of the five certification stages, are more than eighty percent complete in the fourth stage, and are making steady progress through the fifth and final stage. That is the most specific certification progress disclosure Joby has made in any filing I've reviewed, and it represents a meaningful step forward from language in prior quarters.
Sarah: They also flagged the eIPP operations as a significant development.
Mike: Correct. In September 2026, Joby commenced flight operations under the U.S. eVTOL Integration Pilot Program in partnership with the Texas Department of Transportation and in coordination with the FAA. The MD&A describes these as piloted vertical takeoff and landing flights in the Dallas-Fort Worth region. Management characterized these as, quoting directly, "an important step in our preparations for commercial service, providing opportunities to develop operational procedures, demonstrate aircraft performance in real-world environments, and advance coordination with regulators and local stakeholders." That language is carefully calibrated — they are not claiming revenue from these flights, but they are establishing operational credibility ahead of type certification.
Sarah: And they are still targeting first passenger flights in 2026, which is the current calendar year.
Mike: That target is restated in this filing. Given that the filing covers the period ending September 30, 2026, and was filed November 5, 2026, the window for that target is narrow. The eIPP flights in Dallas-Fort Worth represent the operational activity closest to that goal. Management does not walk back the 2026 passenger target in this filing, but they also do not provide a specific date or market for it.
Sarah: Let's move to the financial red flags, because there are several worth naming precisely.
Mike: The most important number in this filing is not revenue and it is not operating loss. It is the accumulated deficit: three point three five billion dollars as of September 30, 2026. That figure represents every dollar Joby has spent since its founding in 2009 in excess of what it has earned. For comparison, the company's total stockholders' equity stands at one point seven five billion dollars — meaning the accumulated deficit is nearly double the current equity base. This is not unusual for a deep-technology aerospace company at this stage, but it is the correct frame for understanding the scale of capital that has been consumed before a single eVTOL passenger has paid for a ride.
Sarah: And the cash burn rate is the operational signal that matters most here.
Mike: Exactly. Cash and equivalents stood at five hundred twenty-one point five million dollars as of September 30, 2026. That is up a hundred and fifty percent from two hundred eight point four million at the same point one year earlier, which tells you the company raised significant capital over the past twelve months. But with an operating loss running at roughly two hundred seventy-eight million per quarter, the arithmetic is straightforward: at the current burn rate, the existing cash balance represents less than two quarters of runway. That is a high-wire execution scenario with limited margin for error. The causality chain here is direct: if the burn rate holds and no additional capital is raised, the company faces a liquidity constraint before type certification is complete. That changes the investment case from a certification bet to a dilution bet.
Sarah: And there is a five-hundred-million-dollar acquisition pending on top of that.
Mike: The Resonant Sciences acquisition, announced August 8, 2026, is priced at approximately five hundred million dollars. The structure is primarily cash, with stock consideration payable to management members equal to forty percent of their portion of the purchase price, totaling approximately fifty million dollars in stock at a per-share price of seven dollars and forty-seven cents. The cash component of this deal, if it closes, would represent a material draw on the existing balance. The filing notes the closing is subject to regulatory approvals and a pre-closing restructuring of Resonant Sciences. This acquisition is not yet reflected in the balance sheet, but it is a forward commitment that investors need to price into any liquidity analysis.
Sarah: On the long-term debt side, what does the balance sheet show?
Mike: Long-term debt stands at seven hundred two point six million dollars. Total liabilities have doubled year-over-year, rising from four hundred sixty-nine point nine million to nine hundred forty point four million. Total assets also roughly doubled, from one point three seven billion to two point six nine billion, largely reflecting the Blade acquisition and capital raises. The balance sheet is growing in both directions simultaneously, which is consistent with a company in aggressive pre-revenue build mode. There is no going concern language in this filing, but the liquidity math demands close monitoring every quarter.
Sarah: Let's talk about risk disclosures. The filing notes no new or significantly escalated risk factors versus the prior quarter. But there are sector-specific risks worth naming.
Mike: The filing is candid about regulatory risk in a way that deserves attention. Management states explicitly that if the FAA requires further modifications to the existing G-1 certification basis, or makes subsequent modifications to the Special Federal Aviation Regulations published in October 2024, this could delay type certification and delay commercial passenger service. They also flag that competitors could reach market before Joby, either generally or in specific markets, and that even a first-mover advantage may not translate into a durable competitive position. The filing states directly, and I'm quoting: "Even if we are first to market, we may not receive any competitive advantage or may be overtaken by other competitors." That is unusually candid language for a company that has consistently emphasized its certification lead.
Sarah: The tariff risk is also flagged, even though it hasn't materialized yet.
Mike: Correct. Management identifies tariffs as a future risk as manufacturing scales, though they note tariffs have not materially impacted operations to date. Given that Joby is building toward a domestic manufacturing operation, the tariff exposure is more of a medium-term concern than an immediate one. But it is worth noting that this risk is being flagged now, before the production facility is operational, which suggests management is thinking ahead about supply chain cost structures.
Sarah: Let's get into the liquidity and balance sheet section in more detail, because the Resonant Sciences deal changes the picture materially.
Mike: From a cash flow standpoint, the company enters the fourth quarter of 2026 with five hundred twenty-one point five million in cash and equivalents. Against a quarterly operating loss of two hundred seventy-eight million, that is approximately one point nine quarters of runway at current burn — call it less than two quarters. Now, the operating loss includes significant non-cash items like stock-based compensation, so the actual cash outflow per quarter is lower than the reported operating loss. But even adjusting for non-cash charges, the runway is measured in quarters, not years. The pending Resonant Sciences acquisition adds approximately four hundred fifty million in net cash consideration on top of that. The filing is clear that the company has historically funded operations through stock issuances and convertible notes, and the balance sheet trajectory — stockholders' equity up nearly ninety-five percent year-over-year to one point seven five billion — confirms that equity raises have been the primary funding mechanism.
Sarah: Which brings us to dilution risk.
Mike: The share count has grown substantially. The EPS figure for the third quarter of 2026 was negative twenty-two cents, compared to negative forty-eight cents in the same quarter of 2025 — an improvement of twenty-six cents per share. But that improvement is partly a function of a larger share count absorbing the same loss, not purely a reduction in the underlying loss. Any follow-on equity raise to fund the Resonant Sciences acquisition or ongoing operations would further dilute existing shareholders. The filing does not telegraph a specific raise, but the capital requirements make one a near-mathematical certainty within the next two to three quarters.
Sarah: Let's look at the segment picture, because Joby now has two distinct revenue streams even if neither is eVTOL commercial service yet.
Mike: The revenue base has two components. First, Blade's air charter brokerage operations, which are the dominant revenue driver at fifty-five point one million for the quarter. The MD&A notes that Blade revenue is seasonal, peaking in the second and third quarters due to summer travel demand. That means the fourth quarter of 2026 and the first quarter of 2027 will show sequential revenue declines from Blade, which is a normal seasonal pattern but one that will compress the reported top line at a time when costs continue to rise. Second, government flight services revenue, which the MD&A notes actually declined year-over-year, partially offsetting Blade's growth. The U.S. Air Force contract expanded from twenty million to nearly thirty-seven million, but the overall government revenue line moved lower, suggesting some contracts rolled off or were restructured.
Sarah: And the Resonant Sciences acquisition is designed to formalize and scale the defense segment.
Mike: That is management's stated rationale. The filing describes Resonant Sciences as becoming Joby's dedicated defense business, with existing defense initiatives — built on more than a decade of work with defense and intelligence customers — expected to be combined under that entity. The explicit goal is to allow the commercial aviation organization to maintain its primary focus on certifying, manufacturing, and commercializing the electric air taxi. From a capital allocation lens, this is a significant strategic bet: spending five hundred million dollars to separate the defense business at a moment when the commercial certification program is in its most critical phase.
Sarah: Let's close with what traders and investors should be watching, and whether the evidence from this filing confirms or modifies our opening thesis.
Mike: The metrics that matter most in the next two quarters are these: first, any update on FAA type certification stage four completion and the transition to stage five. Management said they are more than eighty percent through stage four — the next filing will tell us whether that number moved. Second, the closing of the Resonant Sciences acquisition and the cash impact on the balance sheet. Third, any capital raise announcement, which the liquidity math makes highly probable. Fourth, eIPP expansion — management said they expect to expand activities in the Dallas-Fort Worth region and potentially other high-density markets, and any named market or timeline would be a meaningful signal.
Sarah: And what would prove the thesis wrong?
Mike: Two specific scenarios would contradict our core thesis. First, if Joby announces FAA type certification — or a definitive TC issuance date — within the next two quarters, the burn-versus-milestone race resolves in their favor and the structural reset phase ends. The investment case transforms from a dilution bet into a commercialization bet, which carries a fundamentally different risk profile. Second, if a strategic backer — Toyota, the U.S. Department of Defense, or a new partner — commits a large capital infusion at a valuation that does not require significant dilution, the runway concern evaporates and the thesis weakens substantially. Neither of those outcomes is in this filing, but both are plausible given the certification progress disclosed.
Sarah: So where does the full weight of evidence leave the thesis?
Mike: Confirmed, and sharpened. Joby is closer to type certification than at any prior point in its history — more than eighty percent through stage four of five is a real milestone. But the cash balance covers less than two quarters at current burn, a five-hundred-million-dollar acquisition is pending, and the defense pivot is consuming management bandwidth at the worst possible moment. This equity trades like a deep-option on FAA certification, not like an operating company. At current burn rates and with the Resonant Sciences commitment outstanding, the next capital raise is not a question of if — it is a question of at what price and on what terms.
Sarah: That is the filing in full. If you want this kind of same-week analysis every time a major aviation company reports, follow the show — it is the fastest way to stay ahead of the next filing.
Mike: A reminder that nothing in this episode constitutes investment advice. All figures and statements are drawn directly from Joby Aviation's ten-Q filing for the period ending September 30, 2026, filed November 5, 2026. We are analysts reading a public document, not financial advisors.
Sarah: For Aviation Intelligence Weekly, I'm Sarah.
Mike: And I'm Mike. We'll see you next week.
How this brief was checked
Before any audio was produced, this script was checked claim by claim against the source filing and market data: 48 claims checked, 42 verified against source data, 0 critical issues and 6 minor issues found on 2026-11-06.
JetExpat is an AI-generated publication with an automated verification step and a human approval gate. That process has limits, and we set them out plainly — see how it works. Always verify against the original filing before acting on a number.
Never miss an episode
New weekly aviation market briefs, plus same-week earnings analysis whenever a tracked company files a 10-Q or 10-K. Subscribe on your favorite platform.